Problems occurring in the application of cytogenetic biomarkers for alcoholics with and without malignant diseases;Biomarkerek alkalmazása során felmerülo problémák malignus és nem malignus betegségben szenvedo alkoholisták esetében

Magyar Onkologia

Volumn 52, Issue 2, 2008, Pages 153-161

  Gundy, Sarolta ^a   Székely, Gábor ^a   Farkas, Gyöngyi ^a   Pulay, Attila ^b   Remenár, Éva ^b  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b Alkohológiai Osztály ^*  (Hungary)

Author keywords

Alcohol; Cancer risk; Chromosomes; Inflammation; Self report; Smoking

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

ADULT; AGED; ALCOHOL LIVER DISEASE; ALCOHOLISM; ARTICLE; CHROMOSOME ANALYSIS; DRINKING BEHAVIOR; EPIDEMIOLOGY; FEMALE; GENETICS; HEAD AND NECK TUMOR; HUMAN; IMMUNOLOGY; LYMPHOCYTE; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; SMOKING;

ADULT; AGED; ALCOHOL DRINKING; ALCOHOLISM; BIOLOGICAL MARKERS; CONFOUNDING FACTORS (EPIDEMIOLOGY); CYTOGENETIC ANALYSIS; FEMALE; HEAD AND NECK NEOPLASMS; HEPATITIS, ALCOHOLIC; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; SMOKING; TUMOR MARKERS, BIOLOGICAL;

EID: 55249089078     PISSN: 00250244     EISSN: 20600399     Source Type: Journal    
DOI: 10.1556/MOnkol.52.2008.2.3     Document Type: Article

References (79)

1. A llen JP, Litten RZ. The role of laboratory tests in alcoholism treatment. J Subst Abuse Treat 20:81-85, 2001
2. B alkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 357:539-545, 2001
3. B iró A, Pállinger É, Falus A, et al. Immuntoxikológiai vizsgálatok alkalmazása a kockázati csoportok jellemzésében. Magyar Onkológia 48:137-139, 2004
4. B offetta P, Hashibe M. Alcohol and cancer. Lancet Oncol 7:149-156, 2006
5. B offetta P, Hashibe M, La Vecchia C, et al. The burden of cancer attributable to alcohol drinking. Int J Cancer 119:884-887, 2006
6. B offetta P, van der Hel O, Norppa H, et al. Chromosomal aberrations and cancer risk: Results of a cohort study from Central Europe. Am J Epidemiol 165:36-43, 2006
7. B osetti C, Levi F, Lucchini F, et al. Worldwide mortality from cirrhosis: an update to 2002. J Hepatol 46:827-839, 2007
8. B rennan P, Lewis S, Hashibe M, et al. Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review. Am J Epidemiol 159:1-16, 2004
9. B rooks PJ. DNA damage, DNA repair, and alcohol toxicity-A review. Alcohol Clin Exp Res 21:1073-1082, 1997
10. B urim RV, Canalle R, Takahashi CS, et al. Clastogenic effect of ethanol in chronic and abstinent alcoholics. Mutat Res 560:187-198, 2004
11. Carrano AV, Natarajan AT. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication no. 14. Considerations for population monitoring using cytogenetic techniques. Mutat Res 204:379-406, 1988
12. Chikamatsu K, Sakakura K, Yamamoto T, et al. CD4+ T helper responses in squamous cell carcinoma of the head and neck. Oral Oncol 2008, oi:10.1016/j.oraloncology.2007.11.001
13. Cloos J, Braakhuis BJ M, Steen I, et al. Increased mutagen sensitivity in head-And-neck squamous-cell carcinoma patients, particularly those with multiple primary tumors. Int J Cancer 56:816-819, 1994
14. Cloos J, Spitz MR, Schantz SP, et al. Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst 88:530-535, 1996
15. Cloos J, Steen I, Timmerman AJ, et al. DNA-damage processing in blood lymphocytes of head-And-neck-squamous-cell-carcinoma patients is dependent on tumor site. Int J Cancer 68:26-29, 1996
16. Comprehensive handbook of alcohol related pathology. Eds. Preedy VR, Watson RR. Elsevier Academic Press, San Diego, 2005
17. Conigrave KM, Davies P, Haber P, et al. Traditional markers of excessive alcohol use. Addiction 98(Suppl 2):31-43, 2003
18. Coussens LM, Werb Z. Inflammation and cancer. Nature 420:860-867, 2002
19. Didkowska J, Manczuk M, McNeill A, et al. Lung cancer mortality at ages 35-54 in the European Union: ecological study of evolving tobacco epidemics. BMJ 331:189-191, 2005
20. E lekes Z. Alkohol és társadalom. Országos Addiktológiai Intézet, Budapest, 2004
21. Farrow B, Evers BM. Inflammation and the development of pancreatic cancer. Surg Oncol 10:153-169, 2002
22. Fleming MF, Mundt MP, French MT, et al. Brief physician advice for problem drinkers: long-Term efficacy and benefit-cost analysis. Alcohol Clin Exp Res 26:36-43, 2002
23. French SW. Alcoholic hepatitis: inflammatory cell-mediated hepatocellular injury. Alcohol 27:43-46, 2002
24. Funk S. Új lehetségek az alkoholizmus kezelé sében. Hippocrates 5:94-99, 2003
25. Gajecka M, Jarmuz M, Szyfter W, et al. Non-random distribution of chromatid breaks in lymphocytes of laryngeal squamous cell carcinoma patients. Oncol Rep 12:153-157, 2004
26. Gundy S, Katz N, Füzy M, et al. Cytogenetic study of radiation burden in thyroid disease patients treated with external irradiation or radioiodine. Mutat Res 360:107-113, 1996
27. Hoeksema HL, de Bock GH. The value of laboratory tests for the screening and recognition of alcohol abuse in primary care patients. J Fam Pract 37:268-276, 1993
28. Hsu TC, Johnston DA, Cherry LM, et al. Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer 43:403-409, 1989
29. IAR C. Tobacco smoking summary of data reported and evaluation tobacco smoking. In: Monographs on the evaluation of carcinogenic risks to humans. IAR C Monographs 38, Lyon, 1986
30. IAR C. Alcohol drinking summary of data reported and evaluation alcohol drinking. In: Monographs on the evaluation of carcinogenic risks to humans. IAR C Monographs 44, Lyon, 1988
31. I mmunbiológia. Szerk: Gergely J, Erdei A, Medicina, Budapest, 2000
32. I mmunobiology: the immune system in health and disease-sixth edition. Eds. Janeway C, Travers P, Walport M, et al. Garland Science Publishing, New York, 2004
33. I nternational Head and Neck Cancer Epidemiology, http://inhance. iarc.fr
34. I shikawa H, Ishikawa T, Yamamoto H, et al. Genotoxic effects of alcohol in human peripheral lymphocytes modulated by ADH1B and AL DH2 gene polymorphisms. Mutat Res 615:134-142, 2007
35. J ohnson N. Tobacco use and oral cancer: a global perspective. J Dent Educ 65:328-339, 2001
36. J ousilahti P, Rastenyte D, Tuomilehto J. Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke 31:1851-1855, 2000
37. KS H. A dohányzás hatása a halandósá gra Magyarországon, 1970-1999, Budapest, 2002
38. KS H. Az alkohol hatása a halandóságra Magyarországon, 1970-1999, Budapest, 2003
39. KS H. Demográfiai évkönyv. Budapest, 2004
40. L angseth L. Oxidants, antioxidants and disease prevention. ILSI Europe, Brussels, 1995
41. L atvala J, Parkkila S, Melkko J, et al. Acetaldehyde adducts in blood and bone marrow of patients with ethanol-induced erythrocyte abnormalities. Mol Med 7:401-405, 2001
42. L a Vecchia C, Lucchini F, Negri E, et al. Trends in oral cancer mortality in Europe. Oral Oncol 40:433-439, 2004
43. L engyel G, Fehér J. Az alkohol okozta májká rosodás klinikuma és kezelése. Hippocrates 5:79-84, 2003
44. L eon DA, McCambridge J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data. Lancet 367:52-56, 2006
45. L evi F, Lucchini F, Negri E, et al. Trends in cancer mortality in the European Union and accession countries, 1980-2000. Ann Oncol 15:1425-1431, 2004
46. L ong JC, Knowler WC, Hanson RL, et al. Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. Am J Med Genet 81:216-221, 1998
47. Maffei F, Forti GC, Castelli E, et al. Biomarkers to assess the genetic damage induced by alcohol abuse in human lymphocytes. Mutat Res 514:49-58, 2002
48. Menon KV, Gores GJ, Shah VH. Pathogenesis, diagnosis and treatment of alcoholic liver disease. Mayo Clin Proc 76:1021-1029, 2001
49. Michalska J, Motykiewicz G, Kalinowska E, et al. Bleomycin sensitivity test in the exposed and reference human populations. Mutat Res 418:43-48, 1998
50. Morvai V. Az alkohol és a cardiovascularis betegségek. Hippocrates 5:88-91, 2003
51. N emesánszky E, Juhász P. Az alkoholabusus és alkohol okozta szervi károsodások felismerése laboratóriumi vizsgálatokkal. LAM 3:304-310, 1993
52. N emesánszky E, Pár A. A máj diagnosztikája. In: Gasztroenterológia, Szerk. Varró V., Medicina, Budapest, 1998, pp 385-412
53. N iemelä O, Parkkila S. Alcoholic macrocytosis-is there a role for acetaldehyde and adducts? Addict Biol 9:3-10, 2004
54. N iemelä O. Biomarkers in alcoholism. Clin Chim Acta 377:39-49, 2007
55. N orppa H. Genetic susceptibility, biomarker responses, and cancer. Mutat Res 544:339-348, 2003
56. N orppa H, Bonassi S, Hansteen IL, et al. Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat Res 60:37-45, 2006
57. Ottó S, Kásler M. A hazai és nemzetközi daganatos halálozási és megbetegedési mutatók alakulása: a népegészségügyi programok jellegzetességei és várható eredményei. Magyar Onkológia 49:99-107, 2005
58. Phillips BJ, Jenkinson P. Is alcohol genotoxic? A review of published data. Mutagenesis 16:91-101, 2001
59. Pöschl G, Seitz HK. Alcohol and cancer. Alcohol Alcohol 39:155-165, 2004
60. Pompella A, Corti A, Paolicchi A, et al. Gamma-glutamyltransferase, redox regulation and cancer drug resistance. Curr Opin Pharmacol 7:360-366, 2007
61. R eich T, Edenberg HJ, Goate A, et al. A genome-wide search for genes affecting the risk for alcohol dependence. Am J Med Genet 81:207-215, 1998
62. R emenár É, '53zámel I, Budai B, et al. Szex szteroid-és hypophysishormonok valamint a májfunkció összehasonlító vizsgálata egészséges, alkoholista és fej-nyaki laphámrákos férfiakban. Magyar Onkológia 46:329-333, 2002
63. S chwartz SM, Doody DR, Fitzgibbons ED, et al. Oral squamous cell cancer risk in relation to alcohol consumption and alcohol dehydrogenase-3 genotypes. Cancer Epidemiol Biomarkers Prev 10:1137-1144, 2001
64. S eitz HK, Suter PM. Ethanol toxicity and nutritional status. In: Nutritional Toxicology. Eds. Cotsones FN, McKay MA. Taylor and Francis, London-New York, 2002, pp 122-154
65. S hkolnikov V, McKee M, Leon DA. Changes in life expectancy in Russia in the mid-1990s. Lancet 357:917-921, 2001
66. S mith GR, Missailidis S. Cancer, inflammation and the AT 1 and AT 2 receptors. J Inflamm 1:1-12, 2004
67. S pitz MR, Fueger JJ, Beddingfield NA, et al. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res 49:4626-4628, 1989
68. S pitz MR, McPherson RS, Jiang H, et al. Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. Cancer Epidemiol Biomarkers Prev 6:687-692, 1997
69. S tickel F, Schuppan D, Hahn EG, et al. Cocarcinogenic effects of alcohol in hepatocarcinogenesis. Gut 51:132-139, 2002
70. S zékely G, Remenár É, Kásler M, et al. A kromoszómaanalízis és a bleomycin-Teszt hazai alkalmazhatóságának vizsgálata a fej-nyaki laphámrák prevenciójában. Orvosi Hetilap 142:611-616, 2001
71. S zékely G, Remenár É, Kásler M, et al. Does bleomycin sensitivity assay express cancer phenotype? Mutagenesis 18:59-63, 2003
72. S zcs S, Sárváry A, McKee M, et al. Could the high level of cirrhosis in central and eastern Europe be due partly to the quality of alcohol consumed? An exploratory investigation. Addiction 100:536-542, 2005
73. T opinka J, Binkova B, Sram RJ, et al. DNA-repair capacity and lipid peroxidation in chronic alcoholics. Mutat Res 263:133-136, 1991
74. V adász I. A tüdgyógyászat és a dohányzás mai összefüggései. Hippocrates 7:13-18, 2005
75. V erastegui E, Morales R, Barrera JL, et al. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck. Clin Immunol 102:37-47, 2002
76. W hitfield JB. ADH and AL DH genotypes in relation to alcohol metabolic rate and sensitivity. Alcohol Alcohol 2(Suppl):59-65, 1994
77. W HO, EU. Health status overview for countries of Central and Eastern Europe that are candidates for accession to the European Union, 2002, Documents, E76888
78. W u X, Gu J, Hong WK, et al. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer Inst 90:1393-1399, 1998
79. Z atonski W, Rehm J. The burden of cancer attributable to alcohol drinking. Int J Cancer 119:884-887, 2006